MENU
IMVT
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Immunovant (IMVT) Earnings Date & Reports
Immunovant Inc is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases... Show more
A.I. Advisor
published Earnings
IMVT is expected to report earnings to fall 17.19% to -60 cents per share on August 12
Q2'26
Est.
$-0.60
Q1'26
Missed
by $0.13
Q4'25
Beat
by $0.11
Q3'25
Missed
by $0.02
Q2'25
Missed
by $0.01
The last earnings report on May 20 showed earnings per share of -73 cents, missing the estimate of -60 cents. With 3.34M shares outstanding, the current market capitalization sits at 7.91B.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information
General Information
a clinical-stage biopharmaceutical company, which focuses on enabling normal lives for patients with autoimmune diseases.
Industry Biotechnology
Profile
Details
Industry
N/A
Address
320 West 37th Street
Phone
+1 917 580-3099
Employees
362
Web
https://www.immunovant.com